What is the recommended treatment protocol for Platelet-Rich Plasma (PRP) therapy for hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PRP Therapy for Hair Loss: Evidence-Based Treatment Protocol

Administer three intradermal PRP injection sessions spaced exactly one month apart (months 0,1, and 2), combined with topical minoxidil 5% applied twice daily, followed by maintenance PRP injections every 6 months to sustain results. 1, 2

Treatment Protocol

Initial Treatment Phase

  • Three treatment sessions delivered at precisely one-month intervals (baseline, month 1, month 2) 1, 2
  • Injection technique: Point-by-point delivery at 90-degree angle, 2-4 mm depth, spacing injections 1 cm apart across mapped areas of hair loss 1
  • Volume per session: 5-7 mL of PRP using 30-gauge × 4 mm needles 1
  • Concurrent therapy: Topical minoxidil 5% at 1 mL applied twice daily throughout treatment and beyond 1, 2

PRP Preparation Specifications

  • Use nonactivated PRP only—activation before injection should be avoided as nonactivated PRP demonstrates 31% greater increases in hair count and total hair density compared to activated PRP 1, 2
  • Target platelet concentration: 1.0-1.5 million platelets per microliter using manual double-spin centrifugation method 1
  • Process autologous blood immediately after collection 1

Maintenance Phase

  • Maintenance injections every 6 months are mandatory to sustain results, as discontinuation results in complete loss of gains within months 1, 3
  • Continue topical minoxidil 5% twice daily indefinitely 2

Expected Outcomes and Timeline

Early Response Indicators

  • Initial improvements become visible at 2-3 months of continuous therapy 1, 3
  • A 25% improvement in hair density at 2 months predicts sustained response at 6 months 1, 2

Six-Month Results

  • Hair density increases by 1.74 times baseline 1, 2
  • Hair diameter increases by 14.3 times baseline 1, 2
  • Telogen phase hair decreases by 9.3 times 1
  • Mean hair density increases from approximately 34 hairs/cm² to 50 hairs/cm² 4
  • Terminal to vellus hair ratio improves in 60% of patients 4

Combination Therapy Superiority

The combination of PRP with topical minoxidil 5% is significantly more effective than either monotherapy, and both monotherapies are superior to placebo. 5, 1, 2

  • PRP with minoxidil demonstrates the highest treatment efficacy and patient satisfaction scores compared to either treatment alone 5, 6
  • For maximal efficacy, the triple combination (PRP + minoxidil + finasteride) represents the most effective evidence-based approach 3

Patient Selection and Response Prediction

Best Candidates

  • Mild to moderate androgenetic alopecia responds most favorably to PRP treatment 1, 2
  • More severe grades show variable results 1
  • Both male and female pattern hair loss respond to treatment 7, 4

Monitoring Treatment Response

  • Use trichoscopy to evaluate hair density and diameter 2
  • Standardized before-and-after photographs 2
  • Patient self-assessment questionnaires 2
  • Hair pull test (becomes significantly negative in 83% of patients after treatment) 5

Safety Profile and Adverse Effects

  • Pain during injection is the primary complaint, though generally well-tolerated 5, 1
  • Apply pharmaceutical-grade topical anesthetic before injection to minimize discomfort 1
  • No serious adverse effects reported in clinical studies 7, 4, 6, 8
  • Minoxidil is better tolerated than PRP in terms of pain, but PRP avoids systemic side effects 5

Critical Clinical Pitfalls to Avoid

Common Errors

  • Do not use activated PRP—this reduces efficacy by 31% compared to nonactivated preparations 1, 2
  • Do not skip maintenance injections—results are not permanent and require ongoing treatment every 6 months 1, 3
  • Do not use PRP as monotherapy—always combine with topical minoxidil 5% for superior outcomes 5, 1, 2
  • Do not expect results before 2-3 months—early discontinuation due to perceived lack of response is a common mistake 1, 3

Treatment Discontinuation Consequences

  • Continuous treatment is mandatory to maintain benefits 1, 3
  • Discontinuation results in complete loss of gains within months 2, 3
  • Relapse of androgenetic alopecia occurs 12-16 months after stopping treatment 8

Emerging Alternative: Platelet-Rich Fibrin (PRF)

  • PRF is emerging as a potentially superior alternative to PRP with theoretical advantages including lower cost and easier preparation 1
  • PRF demonstrates similar clinical efficacy and safety profile to PRP 1
  • Consider PRF as an alternative when cost or preparation complexity is a barrier 1

Patient Satisfaction Data

  • Average patient satisfaction score: 7.29/10 7
  • Clinician satisfaction score: 6.46/10 7
  • Likelihood of recommending treatment to friends: 8/10 7
  • Reported improvements: hair density (64%), new hair growth (57%), less hair loss (48%), increased thickness (38%) 7

References

Guideline

Platelet-Rich Plasma (PRP) Treatment for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evidence-Based Treatments for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Combination Therapy for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.